SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Convertible Notes Payable, Noncurrent
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Convertible Notes Payable, Noncurrent of $135.09 thousand as of 2023-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2025-02-26
- 2023-12-31: Convertible Notes Payable, Noncurrent $135.09K.
- 2023-09-30: Convertible Notes Payable, Noncurrent $134.38K.
- 2023-06-30: Convertible Notes Payable, Noncurrent $122.31K.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2023-12-31 | $135.09K 10-K · filed 2025-02-26 |
| 2023-09-30 | $134.38K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $122.31K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |